| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07671560 | Efficacy and Safety of Ensartinib Combined With Anlotinib in Lorlatinib-Resistant… | ALK-positive, Locally Advanced or Metastatic (TNM Stage IIIB-IV) Non-small Cell Lung Cancer That Has Developed Resistance to Prior Treatment With Lorlatinib | Not Yet Recruiting |
| Phase 2 | |||
| NCT06971406 | High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the… | Non Small Cell Lung Cancer | Not Yet Recruiting |
| Not specified | |||
| NCT06926803 | A Clinical Study of Furmonertinib in the Treatment of EGFR-Mutated NSCLC With… | Lung Cancer (NSCLC) | Active, Not Recruiting |